Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44–68.

Article  PubMed  Google Scholar 

Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431–40.

Article  PubMed  Google Scholar 

Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018;19:1–18.

Article  Google Scholar 

Puiu R, Motoc NS, Lucaciu S, Ruta MV, Rajnoveanu R-M, Todea DA, Man MA. The role of Lung Microbiome in Fibrotic interstitial lung Disease—A systematic review. Biomolecules. 2024;14:247.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salton F, Ruaro B, Confalonieri P, Confalonieri M. Epithelial–mesenchymal transition: a major pathogenic driver in idiopathic pulmonary fibrosis? Volume 56. pp. 608: MDPI; 2020. p. 608.

Salton F, Volpe MC, Confalonieri M. Epithelial–mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis. Medicina. 2019;55:83.

Article  PubMed  PubMed Central  Google Scholar 

Yan F, Wen Z, Wang R, Luo W, Du Y, Wang W, Chen X. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics. BMC Pulm Med. 2017;17:174.

Article  PubMed  PubMed Central  Google Scholar 

Bargagli E, Refini RM, d’Alessandro M, Bergantini L, Cameli P, Vantaggiato L, Bini L, Landi C. Metabolic dysregulation in idiopathic pulmonary fibrosis. Int J Mol Sci 2020, 21.

Mamazhakypov A, Schermuly RT, Schaefer L, Wygrecka M. Lipids - two sides of the same coin in lung fibrosis. Cell Signal. 2019;60:65–80.

Article  CAS  PubMed  Google Scholar 

Podolanczuk AJ, Raghu G, Tsai MY, Kawut SM, Peterson E, Sonti R, Rabinowitz D, Johnson C, Barr RG, Hinckley Stukovsky K, et al. Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study. Thorax. 2017;72:472–4.

Article  PubMed  Google Scholar 

Burkart KM, Manichaikul A, Wilk JB, Ahmed FS, Burke GL, Enright P, Hansel NN, Haynes D, Heckbert SR, Hoffman EA, et al. APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema. Eur Respir J. 2014;43:1003–17.

Article  CAS  PubMed  Google Scholar 

Gowdy KM, Fessler MB. Emerging roles for cholesterol and lipoproteins in lung disease. Pulm Pharmacol Ther. 2013;26:430–7.

Article  CAS  PubMed  Google Scholar 

Kim HS, Moon S-J, Lee SE, Hwang GW, Yoo HJ, Song JW. The arachidonic acid metabolite 11, 12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis. Exp Mol Med. 2021;53:864–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HS, Yoo HJ, Lee KM, Song HE, Kim SJ, Lee JO, Hwang JJ, Song JW. Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis. Respirology. 2021;26:255–63.

Article  PubMed  Google Scholar 

Kim TH, Lee YH, Kim KH, Lee SH, Cha JY, Shin EK, Jung S, Jang AS, Park SW, Uh ST, et al. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am J Respir Crit Care Med. 2010;182:633–42.

Article  CAS  PubMed  Google Scholar 

Lee E, Lee EJ, Kim H, Jang A, Koh E, Uh ST, Kim Y, Park SW, Park CS. Overexpression of apolipoprotein A1 in the lung abrogates fibrosis in experimental silicosis. PLoS ONE. 2013;8:e55827.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiao YL, Wu MP. Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid. Cytokine. 2008;43:83–7.

Article  CAS  PubMed  Google Scholar 

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van Der Grinten C, Gustafsson P. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.

Article  CAS  PubMed  Google Scholar 

Macintyre N, Crapo R, Viegi G, Johnson D, Van Der Grinten C, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–35.

Article  CAS  PubMed  Google Scholar 

Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684–91.

Article  PubMed  Google Scholar 

Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

Article  Google Scholar 

Barochia AV, Kaler M, Weir N, Gordon EM, Figueroa DM, Yao X, Lemma WoldeHanna M, Sampson M, Remaley AT, Grant G et al. Serum levels of small HDL particles are negatively correlated with death or lung transplantation in an observational study of idiopathic pulmonary fibrosis. Eur Respir J 2021, 58.

Rims CR, McGuire JK. Matrilysin (MMP-7) catalytic activity regulates β-catenin localization and signaling activation in lung epithelial cells. Exp Lung Res. 2014;40:126–36.

Article  CAS  PubMed  Google Scholar 

Pastva P AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc. 2007;4:252–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao X, Gordon EM, Figueroa DM, Barochia AV, Levine SJ. Emerging roles of apolipoprotein E and apolipoprotein A-I in the Pathogenesis and treatment of Lung Disease. Am J Respir Cell Mol Biol. 2016;55:159–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mangaraj M, Nanda R, Panda S. Apolipoprotein AI: a molecule of diverse function. Indian J Clin Biochem. 2016;31:253–9.

Article  CAS  PubMed  Google Scholar 

Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med. 1989;170:655–63.

Article  CAS  PubMed  Google Scholar 

Kelly M, Kolb M, Bonniaud P, Gauldie J. Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Design. 2003;9:39–49.

Article  CAS  Google Scholar 

Baek AR, Lee JM, Seo HJ, Park JS, Lee JH, Park SW, Jang AS, Kim DJ, Koh ES, Uh ST. Apolipoprotein A1 inhibits TGF-β1–Induced epithelial-to-mesenchymal transition of alveolar epithelial cells. Tuberc Respir Dis. 2016;79:143–52.

Article  Google Scholar